The FAPESP/LICR Human Cancer Genome Project has recently shown that ampli®cation of expressed gene transcripts by reverse transcript-PCR using arbitrarily chosen primers results in the preferential ampli®cation of the central portion of the transcripts that we named ORESTES (for open reading frame ESTs; PNAS 2000; 97:3491). As most of the available sequences in the existing database correspond to either the 3' or 5' end of cDNAs, sequencing of ORESTES fragments has revealed that approximately one third of the non-redundant compilation showed no similarity to known expressed genes from any organisms and 40% of these ORESTES were predicted to contain ORFs. As of today, we have sequences of approximately 430 000 ORESTES. We are currently analysing the differential expression of genes between prostate cancer and normal prostate snap-frozen specimens of the same patient, with bona®de pathology. This analysis is being performed by cDNA microarray of selected ORESTES as templates for hybridisation with cDNAs from tumours and normal tissue. Preliminary results will be presented at the meeting.
